Cassart Pharma SRL
Cassart Pharma reported total assets of €1.68m at the end of the 2025 financial year (annual accounts filed with the NBB on 02 Jul 2026).
The score of Cassart Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +9226 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Cassart Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 02 Jul 2026
- Year ended 31 Dec 2024filed on 01 Jul 2025
- Year ended 31 Dec 2023filed on 06 Aug 2024
- Year ended 31 Dec 2022filed on 24 May 2023
Cassart Pharma's financial analysis
- Solvency17.4%sector median: 40.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Cassart Pharma
Cassart Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0780.539.006
- VAT number
- BE0780539006
- Peppol
- Registered · 0208:0780539006 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 17 Jan 2022
- Registered office
- 7830 Silly
- Latest accounts
- 2025 · filed on 02 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Cassart Pharma (SRL) has been based in Silly since 2022, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 62,643 € and equity of 292,691 €; its revenue is not published. Its solvency stands at 17.4%, below the median of its sector (40.1%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Cassart Pharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie de Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- JD Farma Retail sale of pharmaceutical products Zedelgem · balance sheet €1.67m
- VVM Pharma Invest Retail sale of pharmaceutical products Waregem · balance sheet €1.66m
- Apotheek Vanderstraeten Retail sale of pharmaceutical products Ghent · balance sheet €1.66m
- Gofran Retail sale of pharmaceutical products Zonhoven · balance sheet €1.71m
- Youken Company Retail sale of pharmaceutical products Frameries · balance sheet €1.64m
- Apoteek Jespers - Cuijpers Retail sale of pharmaceutical products Anderlecht · balance sheet €1.72m
- Sibilia Retail sale of pharmaceutical products Grimbergen · balance sheet €1.62m
Frequently asked questions about Cassart Pharma
What is the revenue of Cassart Pharma?
Cassart Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Cassart Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0780539006 for Cassart Pharma, if the company is VAT-registered. Its company number (CBE) is 0780.539.006.
Where is the registered office of Cassart Pharma?
According to the CBE register, the registered office of Cassart Pharma is in 7830 Silly.
What is the equity of Cassart Pharma?
At the close of the 2025 financial year, the equity of Cassart Pharma amounts to 292,691 €, a solvency of 17.4% of total assets.
Who manages Cassart Pharma?
The register lists 2 active mandates at Cassart Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Cassart Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →